Skip to content

Neurophysiological Study of Sensory and Cognitive Processes in Healthy Children and Adults

Neurophysiological Study of Sensory and Cognitive Processes in Healthy Children and Adults

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03182400
Acronym
PROSCEA
Enrollment
450
Registered
2017-06-09
Start date
2017-06-14
Completion date
2027-06-30
Last updated
2022-09-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Volunteer

Brief summary

It is now widely accepted that autism is linked to a developmental disorder and cerebral function. Our research team (UMR U930 INSERM, François-Rabelais University of Tours, whom Pr F Bonnet-Brilhault is responsible for team Autism) hypothesizes that atypical sensory information processing, especially auditory and / or visual information, could underly the symptoms observed in autism. A better knowledge of the typical development of the sensory and cognitive processes must therefore make it possible in the long term to identify the abnormalities linked to the autism spectrum disorders (ASD). Studies in healthy subjects are therefore necessary in order to identify neurophysiological indices of cerebral functioning and to study their evolution during normal development, making it possible in the future to compare with populations of subjects with ASD. The investigators intend to study the development of all the cognitive processes involved in the processing of sensory and, in particular, auditory and visual information in humans: from low-level perception processes to higher-level cognitive processes (attention, emotion, language, prediction, ...). For this the investigators will use non-invasive neurophysiological explorations (EEG, eye tracking) as well as neuropsychological explorations (Questionnaires or spontaneous language recording). A better understanding of the pathophysiological mechanisms underlying the symptoms observed in autism could ultimately lead to the development of new specific therapeutic strategies, particularly in the field of exchange and development therapy or cognitive remediation .

Interventions

Assessment of cerebral electrical activity Assessment of ocular exploration Neurovegetative assessments

BEHAVIORALNeuropsychological assessment

sub-tests, scales, surveys, reaction time measurement

Sponsors

University Hospital, Tours
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
1 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* Between 1 and 60 years-old * Able to understand and apply instructions for a task * Information of subject or legal representant * Informed written consent of subject or legal representant * Affiliation to the social security system

Exclusion criteria

* Abnormal corrected vision * Abnormal audition * Known personal neurological pathology * Known personal psychiatric problems * Identified difficulties for walking, language, or learning * Exclusion period because of participation to another experimental protocol * Adult with legal protection

Design outcomes

Primary

MeasureTime frameDescription
ERP amplitude (µV)1 houranalysis of ERP amplitude evoked during EEG recording

Secondary

MeasureTime frameDescription
Reaction times (ms)1 hourReaction times collected during behavioral assessment
pupil size (mm)1 hourpupil size measurements acquired with the eye tracker

Countries

France

Contacts

Primary ContactFrederique Bonnet-Brilhault, PhD
f.bonnet-brilhault@chu-tours.fr0247473846
Backup ContactMarie Gomot
gomot@univ-tours.fr0247478664

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026